CL2017001207A1 - Efectos antivirales de la narasina en la alimentación de porcinos - Google Patents

Efectos antivirales de la narasina en la alimentación de porcinos

Info

Publication number
CL2017001207A1
CL2017001207A1 CL2017001207A CL2017001207A CL2017001207A1 CL 2017001207 A1 CL2017001207 A1 CL 2017001207A1 CL 2017001207 A CL2017001207 A CL 2017001207A CL 2017001207 A CL2017001207 A CL 2017001207A CL 2017001207 A1 CL2017001207 A1 CL 2017001207A1
Authority
CL
Chile
Prior art keywords
narasin
antiviral effects
composition
pig feeding
breeding pigs
Prior art date
Application number
CL2017001207A
Other languages
English (en)
Inventor
Thomas Alan Marsteller
Jane Granville Owens
Christopher Leigh Puls
Matthew John Ritter
Kelly Shern Rosenkrans
Thomas Edmund Weber
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CL2017001207A1 publication Critical patent/CL2017001207A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

<p>LA PRESENTE INVENCIÓN SE REFIERE A UNA COMPOSICIÓN PARA MEJORAR INFECCIONES VÍRICAS EN CERDOS DE CRIADERO. LA COMPOSICIÓN CONTIENE NARASINA DE IONÓFORO DE POLIÉTER Y SE SUMINISTRA A LOS CERDOS DE CRIADERO EN UNA FORMA ORALMENTE ACEPTABLE. LA COMPOSICIÓN ES EFICAZ PARA REDUCE LA ELIMINACIÓN VIRAL Y LA GRAVEDAD DE LA DIARREA DESPUÉS DE LA ESTIMULACIÓN EN CERDOS DE CRIADERO CON EL VIRUS DE LA DIARREA EPIDÉMICA PORCINA (PEDV).</p>
CL2017001207A 2014-11-13 2017-05-11 Efectos antivirales de la narasina en la alimentación de porcinos CL2017001207A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462079159P 2014-11-13 2014-11-13

Publications (1)

Publication Number Publication Date
CL2017001207A1 true CL2017001207A1 (es) 2018-01-12

Family

ID=54782806

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017001207A CL2017001207A1 (es) 2014-11-13 2017-05-11 Efectos antivirales de la narasina en la alimentación de porcinos

Country Status (17)

Country Link
US (2) US20170296504A1 (es)
EP (1) EP3217971B1 (es)
JP (1) JP6276469B2 (es)
KR (1) KR101929141B1 (es)
CN (1) CN107106534B (es)
AU (1) AU2015346616B2 (es)
BR (1) BR112017006307A2 (es)
CA (1) CA2963476C (es)
CL (1) CL2017001207A1 (es)
EA (1) EA031870B1 (es)
ES (1) ES2754354T3 (es)
MX (1) MX2017006264A (es)
NZ (1) NZ730374A (es)
PL (1) PL3217971T3 (es)
PT (1) PT3217971T (es)
TW (1) TWI656872B (es)
WO (1) WO2016077282A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000012325A1 (it) * 2020-05-26 2021-11-26 Blueprint Pharma Srl Metotrexato per l’uso nel trattamento di infezioni virali in animali da allevamento
WO2021240375A1 (en) * 2020-05-26 2021-12-02 Blueprint Pharma S.R.L. Methotrexate for use in the pharmaceutical or veterinary prevention and/or treatment of viral infections
CN112843043B (zh) * 2021-02-20 2023-03-14 华中农业大学 盐霉素在制备抗冠状病毒药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038384A (en) 1974-06-10 1977-07-26 Eli Lilly And Company Antibiotic a-28086 and process for production thereof
US3995027A (en) * 1975-06-04 1976-11-30 Eli Lilly And Company Anti-viral method in animals
US4174404A (en) * 1977-10-20 1979-11-13 Eli Lilly And Company Deoxynarasin antibiotics
US4309504A (en) 1980-01-28 1982-01-05 Eli Lilly And Company Process for preparing narasin
US4342829A (en) 1981-05-06 1982-08-03 Eli Lilly And Company Process for preparing narasin
US4824829A (en) * 1984-08-15 1989-04-25 American Cyanamid Company Non-dusting antibiotic, anticoccidial premix compositions and a process for their manufacture
US5834473A (en) * 1993-04-29 1998-11-10 Cultor, Ltd. Method for treating coccidiosis
WO1994024886A1 (en) * 1993-04-29 1994-11-10 Cultor Ltd. Compositions for administration to animals with coccidiosis
UA78486C2 (uk) 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)
KR101140582B1 (ko) * 2009-10-09 2012-05-09 주식회사 옵티팜솔루션 음양곽 추출물을 포함하는 돼지유행성설사병 예방 또는 치료용 조성물
RU2675360C2 (ru) * 2013-02-08 2018-12-19 Луода Фарма Лимитед Способы лечения местных микробных инфекций

Also Published As

Publication number Publication date
WO2016077282A1 (en) 2016-05-19
TW201628611A (zh) 2016-08-16
KR20170066622A (ko) 2017-06-14
BR112017006307A2 (pt) 2017-12-12
NZ730374A (en) 2018-10-26
CN107106534B (zh) 2020-01-21
AU2015346616A1 (en) 2017-04-13
JP6276469B2 (ja) 2018-02-07
US20170296504A1 (en) 2017-10-19
EA031870B1 (ru) 2019-03-29
EP3217971A1 (en) 2017-09-20
TWI656872B (zh) 2019-04-21
JP2017536345A (ja) 2017-12-07
ES2754354T3 (es) 2020-04-17
EA201790831A1 (ru) 2017-09-29
CA2963476C (en) 2019-05-21
CA2963476A1 (en) 2016-05-19
PT3217971T (pt) 2019-11-20
KR101929141B1 (ko) 2018-12-13
MX2017006264A (es) 2017-08-14
US20220265597A1 (en) 2022-08-25
EP3217971B1 (en) 2019-09-11
PL3217971T3 (pl) 2020-03-31
AU2015346616B2 (en) 2018-03-01
CN107106534A (zh) 2017-08-29

Similar Documents

Publication Publication Date Title
CL2017000902A1 (es) Dihidropirrolopiridinas inhibidoras de ror-gamma
CL2017001426A1 (es) Nuevos compuestos de 5-amino-6h-tiazolo[4,5-d]pirimidin-2,7-diona 3-sustituidos para el tratamiento y profilaxis de infecciones virales.
MX2020004495A (es) Composiciones y métodos para tratar la resistencia a los antibióticos.
SV2018005662A (es) Moduladores del receptor x farnesoide
CL2016002877A1 (es) Compuestos de 2-cloro-2-difluorometoxifenil pirazolopirimidina, composiciones y métodos de uso de los mismos.
PE20160167A1 (es) Composiciones y metodos para alterar la senalizacion del segundo mensajero
CL2018001199A1 (es) Composiciones terapéuticas para el tratamiento del virus de inmunodeficiencia humana
UY33885A (es) Inhibición de la il17 y del ifn-gamma para el tratamiento de las inflamaciones autoinmunes
CL2017000092A1 (es) Contenedor flexible con accesorios y proceso para producirlo
CL2017000014A1 (es) Derivados de isondolina para su uso en el tratamiento de una infección viral
UY35298A (es) Formulación en dispersión sólida de un compuesto antiviral
AR098274A1 (es) Inhibidor de grelina o-acil transferasa
CL2017001207A1 (es) Efectos antivirales de la narasina en la alimentación de porcinos
AR094553A1 (es) Formas de oxadiazolpirazina
CL2016000392A1 (es) Análogos de cortistatina para el tratamiento de enfermedades con componente inflamatorio y/o inmune
CR20160192A (es) Formulación de farmaco de liberación retardada
CL2017000152A1 (es) Derivados de isoindolinona
AR103350A1 (es) Composiciones del inhibidor de la nitrificación y métodos de preparación de las mismas
TWD169239S (zh) 附有照相機之投影機
CL2017001483A1 (es) Formulación de relación fija de insulina glargina/lixisenatida
AR099766A1 (es) Inhibidores de la quinasa asociada al adaptador 1, composiciones que los comprenden y métodos para utilizarlos
UY36217A (es) Compuestos piridona sustituídos, composiciones farmacéuticas y métodos de uso.
AR113514A1 (es) Composiciones y métodos para mejorar la utilización del fósforo y el calcio en la dieta de los animales
CL2020002268A1 (es) Métodos para mejorar el rendimiento en rumiantes
CL2018000253A1 (es) Respuesta inmunitaria potenciada de las especies porcinas